We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Prognostic Biomarker Candidates Identified for Ovarian Cancer

By LabMedica International staff writers
Posted on 25 Nov 2014
Print article
Image: Histopathology of ovarian serous papillary borderline tumor, intracystic, without surface cortical involvement (Photo courtesy of Brown University).
Image: Histopathology of ovarian serous papillary borderline tumor, intracystic, without surface cortical involvement (Photo courtesy of Brown University).
Two independent classes of novel candidate prognostic markers for ovarian cancer have been identified advancing efforts to develop targeted therapies for the disease.

An association of this often-deadly cancer has been made with the immune system and clarified the role of a class of immunogenic tumor antigens known as cancer testis (CT) antigens, as the immune system can potently inhibit the growth of cancer cells. These novel findings may enable development of a new strategy for identifying those patients most likely to benefit from particular targeted therapies.

Scientists at the Roswell Park Cancer Institute (Buffalo, NY, USA) establish novel associations between prognosis and the expression of immune-related genes through a focused screen utilizing publicly available high-throughput assays. The Cancer Genome Atlas (TCGA; Bethesda, MD, USA) is a biorepository study of high-grade serous ovarian cancers from multiple centers in the USA and relevant to their analysis, the study strictly included ovarian primaries and papillary serous histologies.

The team found preliminary evidence that some CT antigens are associated with survival when examined in concert with the five-gene signature. Fifteen of 64 immune-related genes were associated with survival of which five were reproduced in a validation set. The expression of these genes defines an immunoreactive (IR) subgroup of patients with a favorable prognosis. Phenotypic characterization of the immune compartment signal includes upregulation of markers of CD8+ T-cell activation in these patients.

Takemasa Tsuji, PhD, an assistant professor of Oncology and co-author of the study said, “CT antigens like the cancer-testis antigen NY-ESO-1 are readily recognized by the immune system and are therefore prime targets for cancer immunotherapies, so this work unveiling interaction between cancer and immune cells has real implications for our development of efficient immunotherapies at the Center for Immunotherapy. Determining patterns of both the immunological markers and CT antigens present in a women's tumor can lead the way to personalized medicine, an approach that uses the best combination of therapeutic modality and target antigen.” The study was published on November 7, 2014, in the journal Public Library of Science ONE.

Related Links:

Roswell Park Cancer Institute 
The Cancer Genome Atlas 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.